引用本文:陈 坤,高电萨,左 中.乳腺癌伴随疾病全方位管理之乳腺癌治疗的心脏毒性管理[J].中国临床新医学,2019,12(2):125-129.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 160次   下载 117 本文二维码信息
码上扫一扫!
分享到: 微信 更多
乳腺癌伴随疾病全方位管理之乳腺癌治疗的心脏毒性管理
陈 坤,高电萨,左 中
400016 重庆,重庆医科大学附属第一医院心血管内科
摘要:
[摘要] 乳腺癌是我国女性最常见的恶性肿瘤。当前,通过手术、放化疗、内分泌治疗、靶向治疗等综合治疗方式,乳腺癌患者的生存率显著提高。但上述治疗方式产生的心脏毒性已成为肿瘤幸存者常见的死亡原因,故在乳腺癌治疗过程中对心脏毒性的评估及心脏保护是很有必要的。该文对乳腺癌相关治疗引起的心脏毒性管理作一综述。
关键词:  乳腺癌治疗  心脏毒性  心脏保护
DOI:10.3969/j.issn.1674-3806.2019.02.04
分类号:R 994.1;R 737.9
基金项目:重庆市科卫联合医学科研重点项目(编号:2018ZDXM010)
Strengthening the comprehensive management of concomitant diseases of breast cancer: cardiac toxicity management in breast cancer treatment
CHEN Kun, GAO Dian-sa, ZUO Zhong
Department of Cardiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
Abstract:
[Abstract] Breast cancer is the most common malignant tumor in Chinese women. At present, the survival rate of breast cancer patients has been gradually elevated by using comprehensive treatment methods such as surgery, radiotherapy and chemotherapy, endocrine therapy and targeted therapy. However, the cardiotoxicity caused by the above treatments has become a common cause of death for cancer survivors, so it is necessary to evaluate cardiotoxicity and protect the heart during the treatments of breast cancer. This article focuses on the management of cardiotoxicity caused by breast cancer related therapies.
Key words:  Breast cancer therapy  Cardiotoxicity  Cardiac protection